Clinical and Immunological Features of 96 Moroccan Children with SCID Phenotype: Two Decades’ Experience

Severe combined immunodeficiency (SCID) is a heterogeneous group of primary immunodeficiency diseases (PIDs) characterized by a lack of autologous T lymphocytes. This severe PID is rare, but has a higher prevalence in populations with high rates of consanguinity. The epidemiological, clinical, and i...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical immunology Vol. 41; no. 3; pp. 631 - 638
Main Authors Benhsaien, Ibtihal, Ailal, Fatima, El Bakkouri, Jalila, Jeddane, Leïla, Ouair, Hind, Admou, Brahim, Bouskraoui, Mohamed, Hbibi, Mohamed, Hida, Mustapha, Amenzoui, Naïma, Jouhadi, Zineb, El Hafidi, Naïma, Rada, Nouredine, Benajiba, Noufissa, Abilkassem, Rachid, Badou, Abdallah, Bousfiha, Ahmed Aziz
Format Journal Article
LanguageEnglish
Published New York Springer US 01.04.2021
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Severe combined immunodeficiency (SCID) is a heterogeneous group of primary immunodeficiency diseases (PIDs) characterized by a lack of autologous T lymphocytes. This severe PID is rare, but has a higher prevalence in populations with high rates of consanguinity. The epidemiological, clinical, and immunological features of SCIDs in Moroccan patients have never been reported. The aim of this study was to provide a clinical and immunological description of SCID in Morocco and to assess changes in the care of SCID patients over time. This cross-sectional retrospective study included 96 Moroccan patients referred to the national PID reference center at Casablanca Children’s Hospital for SCID over two decades, from 1998 to 2019. The case definition for this study was age < 2 years, with a clinical phenotype suggestive of SCID, and lymphopenia, with very low numbers of autologous T cells, according to the IUIS Inborn Errors of Immunity classification. Our sample included 50 male patients, and 66% of the patients were born to consanguineous parents. The median age at onset and diagnosis were 3.3 and 6.5 months, respectively. The clinical manifestations commonly observed in these patients were recurrent respiratory tract infection (82%), chronic diarrhea (69%), oral candidiasis (61%), and failure to thrive (65%). The distribution of SCID phenotypes was as follows: T−B−NK+ in 44.5%, T−B−NK− in 32%, T−B+NK− in 18.5%, and T−B+NK+ in 5%. An Omenn syndrome phenotype was observed in 15 patients. SCID was fatal in 84% in the patients in our cohort, due to the difficulties involved in obtaining urgent access to hematopoietic stem cell transplantation, which, nevertheless, saved 16% of the patients. The autosomal recessive forms of the clinical and immunological phenotypes of SCID, including the T−B−NK+ phenotype in particular, were more frequent than those in Western countries. A marked improvement in the early detection of SCID cases over the last decade was noted. Despite recent progress in SCID diagnosis, additional efforts are required, for genetic confirmation and particularly for HSCT.
AbstractList Severe combined immunodeficiency (SCID) is a heterogeneous group of primary immunodeficiency diseases (PIDs) characterized by a lack of autologous T lymphocytes. This severe PID is rare, but has a higher prevalence in populations with high rates of consanguinity. The epidemiological, clinical, and immunological features of SCIDs in Moroccan patients have never been reported. The aim of this study was to provide a clinical and immunological description of SCID in Morocco and to assess changes in the care of SCID patients over time. This cross-sectional retrospective study included 96 Moroccan patients referred to the national PID reference center at Casablanca Children's Hospital for SCID over two decades, from 1998 to 2019. The case definition for this study was age < 2 years, with a clinical phenotype suggestive of SCID, and lymphopenia, with very low numbers of autologous T cells, according to the IUIS Inborn Errors of Immunity classification. Our sample included 50 male patients, and 66% of the patients were born to consanguineous parents. The median age at onset and diagnosis were 3.3 and 6.5 months, respectively. The clinical manifestations commonly observed in these patients were recurrent respiratory tract infection (82%), chronic diarrhea (69%), oral candidiasis (61%), and failure to thrive (65%). The distribution of SCID phenotypes was as follows: T-B-NK+ in 44.5%, T-B-NK- in 32%, T-B+NK- in 18.5%, and T-B+NK+ in 5%. An Omenn syndrome phenotype was observed in 15 patients. SCID was fatal in 84% in the patients in our cohort, due to the difficulties involved in obtaining urgent access to hematopoietic stem cell transplantation, which, nevertheless, saved 16% of the patients. The autosomal recessive forms of the clinical and immunological phenotypes of SCID, including the T-B-NK+ phenotype in particular, were more frequent than those in Western countries. A marked improvement in the early detection of SCID cases over the last decade was noted. Despite recent progress in SCID diagnosis, additional efforts are required, for genetic confirmation and particularly for HSCT.
Severe combined immunodeficiency (SCID) is a heterogeneous group of primary immunodeficiency diseases (PIDs) characterized by a lack of autologous T lymphocytes. This severe PID is rare, but has a higher prevalence in populations with high rates of consanguinity. The epidemiological, clinical, and immunological features of SCIDs in Moroccan patients have never been reported. The aim of this study was to provide a clinical and immunological description of SCID in Morocco and to assess changes in the care of SCID patients over time. This cross-sectional retrospective study included 96 Moroccan patients referred to the national PID reference center at Casablanca Children’s Hospital for SCID over two decades, from 1998 to 2019. The case definition for this study was age < 2 years, with a clinical phenotype suggestive of SCID, and lymphopenia, with very low numbers of autologous T cells, according to the IUIS Inborn Errors of Immunity classification. Our sample included 50 male patients, and 66% of the patients were born to consanguineous parents. The median age at onset and diagnosis were 3.3 and 6.5 months, respectively. The clinical manifestations commonly observed in these patients were recurrent respiratory tract infection (82%), chronic diarrhea (69%), oral candidiasis (61%), and failure to thrive (65%). The distribution of SCID phenotypes was as follows: T−B−NK+ in 44.5%, T−B−NK− in 32%, T−B+NK− in 18.5%, and T−B+NK+ in 5%. An Omenn syndrome phenotype was observed in 15 patients. SCID was fatal in 84% in the patients in our cohort, due to the difficulties involved in obtaining urgent access to hematopoietic stem cell transplantation, which, nevertheless, saved 16% of the patients. The autosomal recessive forms of the clinical and immunological phenotypes of SCID, including the T−B−NK+ phenotype in particular, were more frequent than those in Western countries. A marked improvement in the early detection of SCID cases over the last decade was noted. Despite recent progress in SCID diagnosis, additional efforts are required, for genetic confirmation and particularly for HSCT.
Severe combined immunodeficiency (SCID) is a heterogeneous group of primary immunodeficiency diseases (PIDs) characterized by a lack of autologous T lymphocytes. This severe PID is rare, but has a higher prevalence in populations with high rates of consanguinity. The epidemiological, clinical, and immunological features of SCIDs in Moroccan patients have never been reported. The aim of this study was to provide a clinical and immunological description of SCID in Morocco and to assess changes in the care of SCID patients over time. This cross-sectional retrospective study included 96 Moroccan patients referred to the national PID reference center at Casablanca Children’s Hospital for SCID over two decades, from 1998 to 2019. The case definition for this study was age < 2 years, with a clinical phenotype suggestive of SCID, and lymphopenia, with very low numbers of autologous T cells, according to the IUIS Inborn Errors of Immunity classification. Our sample included 50 male patients, and 66% of the patients were born to consanguineous parents. The median age at onset and diagnosis were 3.3 and 6.5 months, respectively. The clinical manifestations commonly observed in these patients were recurrent respiratory tract infection (82%), chronic diarrhea (69%), oral candidiasis (61%), and failure to thrive (65%). The distribution of SCID phenotypes was as follows: T−B−NK+ in 44.5%, T−B−NK− in 32%, T−B+NK− in 18.5%, and T−B+NK+ in 5%. An Omenn syndrome phenotype was observed in 15 patients. SCID was fatal in 84% in the patients in our cohort, due to the difficulties involved in obtaining urgent access to hematopoietic stem cell transplantation, which, nevertheless, saved 16% of the patients. The autosomal recessive forms of the clinical and immunological phenotypes of SCID, including the T−B−NK+ phenotype in particular, were more frequent than those in Western countries. A marked improvement in the early detection of SCID cases over the last decade was noted. Despite recent progress in SCID diagnosis, additional efforts are required, for genetic confirmation and particularly for HSCT.
Author Ouair, Hind
El Hafidi, Naïma
Badou, Abdallah
Abilkassem, Rachid
Admou, Brahim
Rada, Nouredine
Ailal, Fatima
Hbibi, Mohamed
Jeddane, Leïla
Bouskraoui, Mohamed
Benajiba, Noufissa
El Bakkouri, Jalila
Amenzoui, Naïma
Benhsaien, Ibtihal
Jouhadi, Zineb
Hida, Mustapha
Bousfiha, Ahmed Aziz
Author_xml – sequence: 1
  givenname: Ibtihal
  surname: Benhsaien
  fullname: Benhsaien, Ibtihal
  organization: Clinical Immunology Unit, Infectious Diseases Department, Children’s Hospital, Ibn Rochd University Hospital, Cellular and Molecular Pathology Laboratory, Faculty of Medicine and Pharmacy, Hassan II University, Clinical Immunology, Autoimmunity and Inflammation Laboratory (LICIA), Faculty of Medicine and Pharmacy, Hassan II University
– sequence: 2
  givenname: Fatima
  surname: Ailal
  fullname: Ailal, Fatima
  organization: Clinical Immunology Unit, Infectious Diseases Department, Children’s Hospital, Ibn Rochd University Hospital, Clinical Immunology, Autoimmunity and Inflammation Laboratory (LICIA), Faculty of Medicine and Pharmacy, Hassan II University
– sequence: 3
  givenname: Jalila
  surname: El Bakkouri
  fullname: El Bakkouri, Jalila
  organization: Clinical Immunology, Autoimmunity and Inflammation Laboratory (LICIA), Faculty of Medicine and Pharmacy, Hassan II University, Immunology Laboratory, Ibn Rochd University Hospital
– sequence: 4
  givenname: Leïla
  surname: Jeddane
  fullname: Jeddane, Leïla
  organization: Clinical Immunology, Autoimmunity and Inflammation Laboratory (LICIA), Faculty of Medicine and Pharmacy, Hassan II University, Laboratoire National de Référence, Mohamed VI Health Sciences University
– sequence: 5
  givenname: Hind
  surname: Ouair
  fullname: Ouair, Hind
  organization: Clinical Immunology, Autoimmunity and Inflammation Laboratory (LICIA), Faculty of Medicine and Pharmacy, Hassan II University
– sequence: 6
  givenname: Brahim
  surname: Admou
  fullname: Admou, Brahim
  organization: Immunology Laboratory, Mohammed VI University Hospital
– sequence: 7
  givenname: Mohamed
  surname: Bouskraoui
  fullname: Bouskraoui, Mohamed
  organization: Department of Pediatric Infectious Diseases, Mohammed VI University Hospital
– sequence: 8
  givenname: Mohamed
  surname: Hbibi
  fullname: Hbibi, Mohamed
  organization: Department of Pediatric Diseases, Hassan II University Hospital
– sequence: 9
  givenname: Mustapha
  surname: Hida
  fullname: Hida, Mustapha
  organization: Department of Pediatric Diseases, Hassan II University Hospital
– sequence: 10
  givenname: Naïma
  surname: Amenzoui
  fullname: Amenzoui, Naïma
  organization: Clinical Immunology Unit, Infectious Diseases Department, Children’s Hospital, Ibn Rochd University Hospital
– sequence: 11
  givenname: Zineb
  surname: Jouhadi
  fullname: Jouhadi, Zineb
  organization: Clinical Immunology Unit, Infectious Diseases Department, Children’s Hospital, Ibn Rochd University Hospital
– sequence: 12
  givenname: Naïma
  surname: El Hafidi
  fullname: El Hafidi, Naïma
  organization: Department of Pediatric Infectious Diseases, Avicenna University Hospital
– sequence: 13
  givenname: Nouredine
  surname: Rada
  fullname: Rada, Nouredine
  organization: Department of Pediatric Infectious Diseases, Mohammed VI University Hospital
– sequence: 14
  givenname: Noufissa
  surname: Benajiba
  fullname: Benajiba, Noufissa
  organization: Department of Pediatrics, Mohammed VI University Hospital
– sequence: 15
  givenname: Rachid
  surname: Abilkassem
  fullname: Abilkassem, Rachid
  organization: Department of Pediatrics, Mohammed V Military Hospital, Faculty of Medicine and Pharmacy, Mohammed V University
– sequence: 16
  givenname: Abdallah
  surname: Badou
  fullname: Badou, Abdallah
  organization: Cellular and Molecular Pathology Laboratory, Faculty of Medicine and Pharmacy, Hassan II University
– sequence: 17
  givenname: Ahmed Aziz
  orcidid: 0000-0002-5011-9873
  surname: Bousfiha
  fullname: Bousfiha, Ahmed Aziz
  email: profbousfiha@gmail.com
  organization: Clinical Immunology Unit, Infectious Diseases Department, Children’s Hospital, Ibn Rochd University Hospital, Clinical Immunology, Autoimmunity and Inflammation Laboratory (LICIA), Faculty of Medicine and Pharmacy, Hassan II University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33411152$$D View this record in MEDLINE/PubMed
BookMark eNp9kcFu1DAQhi1U1G5LX4ADssSll4DHjp01N5S2sFIRlVrO0cSZdLNK7MVO1O2N1-D1eBJCt4DEgdNIM9__z2j-Y3bggyfGXoJ4A0IUbxOIZaEzIUUmhDUi2z1jC9CFyqS28oAthCwgs5DLI3ac0kYIoYzUh-xIqRwAtFywTdl3vnPYc_QNXw3D5EMf7h47l4TjFCnx0HJr-KcQg3Poebnu-iaS5_fduOY35eqcX6_Jh_FhS-_47X3g5-SwofTj23d-sdtS7Mg7esGet9gnOn2qJ-zL5cVt-TG7-vxhVb6_ypwq9JihrptWKDDtEhxYRFU3qtZOWt04myPW2OoGJCqRK2UAVC1aNNqgLRDqVp2ws73vNoavE6WxGrrkqO_RU5hSJfPCgDTGyhl9_Q-6CVP083UzZfMCzNKomZJ7ysWQUqS22sZuwPhQgah-JVHtk6jmJKrHJKrdLHr1ZD3VAzV_JL9fPwNqD6R55O8o_t39H9ufrIuWJQ
CitedBy_id crossref_primary_10_1007_s10875_022_01275_9
crossref_primary_10_1007_s10875_023_01542_3
crossref_primary_10_1016_j_jaip_2022_10_003
crossref_primary_10_1186_s13223_023_00768_5
Cites_doi 10.1007/s10875-017-0465-8
10.1111/cei.12172
10.1016/j.jaci.2009.10.022
10.3389/fimmu.2019.01908
10.1111/nyas.12849
10.1007/s10875-010-9489-z
10.18176/jiaci.0147
10.3389/fimmu.2019.00023
10.1111/j.1365-2249.2009.03954.x
10.1182/blood-2013-02-380105
10.1007/s10875-013-9917-y
10.1007/s10875-020-00758-x
10.3389/fimmu.2018.00782
10.1001/jama.2014.9132
10.1007/s10875-011-9564-0
10.1016/j.jinf.2012.03.012
10.1007/s10875-015-0197-6
10.1016/S0022-3476(05)80951-5
10.1016/j.jaci.2003.07.003
10.1007/s10875-015-0179-8
10.1016/j.jaci.2014.02.028
10.1016/j.jaip.2015.01.026
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021
The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021
– notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7T5
7X7
7XB
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s10875-020-00960-x
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Immunology Abstracts
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

ProQuest Central Student
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-2592
EndPage 638
ExternalDocumentID 10_1007_s10875_020_00960_x
33411152
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Morocco
GeographicLocations_xml – name: Morocco
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29K
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3SX
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67N
67Z
6NX
78A
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AANXM
AANZL
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABELW
ABFGW
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABPTK
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHVE
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACTTH
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADMDM
ADOAH
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFEXP
AFFNX
AFGCZ
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
AOSHJ
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
D-I
DDRTE
DL5
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
L7B
LAK
LK8
LLZTM
M1P
M4Y
M7P
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
RNS
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
VVN
W23
W48
WJK
WK6
WK8
Y6R
YLTOR
Z45
Z7U
Z81
Z82
Z87
Z8O
Z8V
Z91
ZGI
ZMTXR
ZOVNA
~EX
~KM
AACDK
AAEOY
AAJBT
AAQLM
AASML
AAYZH
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
ALIPV
CGR
CUY
CVF
ECM
EIF
H13
NPM
AAYXX
CITATION
7T5
7XB
8FK
AZQEC
DWQXO
GNUQQ
H94
K9.
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c375t-a5bdf0316f81c19aa3bd3b5c295dc94aabaf5d12a304336113b0fa656a97a1bf3
IEDL.DBID AGYKE
ISSN 0271-9142
IngestDate Fri Oct 25 03:20:07 EDT 2024
Tue Oct 22 16:06:16 EDT 2024
Thu Sep 12 19:21:34 EDT 2024
Wed Oct 16 00:42:30 EDT 2024
Sat Dec 16 12:10:13 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords epidemiology
Severe combined immunodeficiency
Morocco
immunophenotype
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-a5bdf0316f81c19aa3bd3b5c295dc94aabaf5d12a304336113b0fa656a97a1bf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-5011-9873
PMID 33411152
PQID 2494716863
PQPubID 37573
PageCount 8
ParticipantIDs proquest_miscellaneous_2476126692
proquest_journals_2494716863
crossref_primary_10_1007_s10875_020_00960_x
pubmed_primary_33411152
springer_journals_10_1007_s10875_020_00960_x
PublicationCentury 2000
PublicationDate 2021-04-01
PublicationDateYYYYMMDD 2021-04-01
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-04-01
  day: 01
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: Netherlands
PublicationSubtitle International Journal of Inborn Errors of Immunity and Related Diseases
PublicationTitle Journal of clinical immunology
PublicationTitleAbbrev J Clin Immunol
PublicationTitleAlternate J Clin Immunol
PublicationYear 2021
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Norouzia, Aghamohammadi, Mamishia, Rosenzweig, Rezaeib (CR21) 2012; 64
Dvorak, Cowan, Logan (CR23) 2013; 33
Cirillo, Giardino, Gallo (CR1) 2015; 1356
Erwa, Jeddane, Alao (CR12) 2015; 35
Almousa, Al-Dakheel, Jabr (CR9) 2018; 9
Al-Saud, Al-Mousa, Al Gazlan (CR8) 2015; 35
Tangye, Al-Herz, Bousfiha (CR6) 2020; 40
Kwan, Abraham, Currier (CR10) 2014; 312
Talbi, Khadmaoui, Soulaymani, Chafik (CR11) 2007; 15
Shearer, Rosenblatt, Gelman (CR4) 2003; 112
Gathmann, Grimbacher, Beauté (CR7) 2009; 157
Fazlollahi, Pourpak (CR18) 2017; 27
Michos, Tzanoudaki, Villa (CR16) 2011; 31
Stephan, Vlekova, Le Deist (CR13) 1993; 123
Marciano, Huang, Joshi (CR22) 2014; 133
CR20
Lee, Chan, Chen (CR15) 2011; 31
Aluri, Desai, Gupta (CR2) 2019; 10
Cirillo, Cancrini, Azzari (CR19) 2019; 10
Edgar, Buckland, Guzman (CR14) 2014; 175
Bobby Gaspar, Qasim, Graham Davies (CR17) 2013; 122
Griffith, Cowan, Notarangelo (CR3) 2009; 124
Bousfiha, Jeddane, Picard (CR5) 2018; 38
H Bobby Gaspar (960_CR17) 2013; 122
E Cirillo (960_CR19) 2019; 10
BE Marciano (960_CR22) 2014; 133
H Almousa (960_CR9) 2018; 9
A Kwan (960_CR10) 2014; 312
S Norouzia (960_CR21) 2012; 64
WT Shearer (960_CR4) 2003; 112
B Gathmann (960_CR7) 2009; 157
NHH Erwa (960_CR12) 2015; 35
A Michos (960_CR16) 2011; 31
960_CR20
CC Dvorak (960_CR23) 2013; 33
E Cirillo (960_CR1) 2015; 1356
SG Tangye (960_CR6) 2020; 40
PP Lee (960_CR15) 2011; 31
LM Griffith (960_CR3) 2009; 124
J Talbi (960_CR11) 2007; 15
AA Bousfiha (960_CR5) 2018; 38
B Al-Saud (960_CR8) 2015; 35
MR Fazlollahi (960_CR18) 2017; 27
JL Stephan (960_CR13) 1993; 123
JD Edgar (960_CR14) 2014; 175
J Aluri (960_CR2) 2019; 10
References_xml – volume: 38
  start-page: 129
  issue: 1
  year: 2018
  end-page: 143
  ident: CR5
  article-title: The 2017 IUIS phenotypic classification for primary immunodeficiencies
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-017-0465-8
  contributor:
    fullname: Picard
– volume: 175
  start-page: 68
  issue: 1
  year: 2014
  end-page: 78
  ident: CR14
  article-title: The United Kingdom Primary Immune Deficiency (UKPID) registry: report of the first 4 years’ activity 2008–2012
  publication-title: Clin Exp Immunol
  doi: 10.1111/cei.12172
  contributor:
    fullname: Guzman
– volume: 124
  start-page: 1152
  issue: 6
  year: 2009
  end-page: 1160
  ident: CR3
  article-title: Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management
  publication-title: J Allergy Clin Immunol.
  doi: 10.1016/j.jaci.2009.10.022
  contributor:
    fullname: Notarangelo
– volume: 10
  start-page: 1908
  year: 2019
  ident: CR19
  article-title: Clinical, immunological, and molecular features of typical and atypical severe combined immunodeficiency: report of the Italian Primary Immunodeficiency Network
  publication-title: Frontiers in Immunol.
  doi: 10.3389/fimmu.2019.01908
  contributor:
    fullname: Azzari
– volume: 1356
  start-page: 90
  year: 2015
  end-page: 106
  ident: CR1
  article-title: Severe combined immunodeficiency--an update
  publication-title: Ann N Y Acad Sci.
  doi: 10.1111/nyas.12849
  contributor:
    fullname: Gallo
– volume: 31
  start-page: 281
  issue: 2
  year: 2011
  end-page: 296
  ident: CR15
  article-title: Molecular diagnosis of severe combined immunodeficiency - identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children
  publication-title: J Clin Immunol.
  doi: 10.1007/s10875-010-9489-z
  contributor:
    fullname: Chen
– volume: 27
  start-page: 299
  issue: 5
  year: 2017
  end-page: 304
  ident: CR18
  article-title: AA. Hamidiehet al. Clinical, laboratory, and molecular findings for 63 patients with severe combined immunodeficiency: a decade's experience
  publication-title: J Investig Allergol Clin Immunol.
  doi: 10.18176/jiaci.0147
  contributor:
    fullname: Pourpak
– volume: 10
  start-page: 23
  year: 2019
  ident: CR2
  article-title: Clinical, immunological, and molecular findings in 57 patients with severe combined immunodeficiency (SCID) from India
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.00023
  contributor:
    fullname: Gupta
– volume: 157
  start-page: 3
  issue: suppl 1
  year: 2009
  end-page: 11
  ident: CR7
  article-title: The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008
  publication-title: Clin Exp Immunol.
  doi: 10.1111/j.1365-2249.2009.03954.x
  contributor:
    fullname: Beauté
– volume: 122
  start-page: 3749
  issue: 23
  year: 2013
  end-page: 3758
  ident: CR17
  article-title: How I treat severe combined immunodeficiency
  publication-title: Blood
  doi: 10.1182/blood-2013-02-380105
  contributor:
    fullname: Graham Davies
– volume: 33
  start-page: 1156
  issue: 7
  year: 2013
  end-page: 1164
  ident: CR23
  article-title: The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency. Treatment consortium prospective study 6901
  publication-title: J Clin Immunol.
  doi: 10.1007/s10875-013-9917-y
  contributor:
    fullname: Logan
– volume: 40
  start-page: 66
  issue: 1
  year: 2020
  end-page: 81
  ident: CR6
  article-title: Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-020-00758-x
  contributor:
    fullname: Bousfiha
– volume: 9
  start-page: 782
  year: 2018
  ident: CR9
  article-title: High incidence of severe combined immunodeficiency disease in Saudi Arabia detected through combined T cell receptor excision circle and next generation sequencing of newborn dried blood spots
  publication-title: Front immunol
  doi: 10.3389/fimmu.2018.00782
  contributor:
    fullname: Jabr
– volume: 15
  start-page: 1
  year: 2007
  end-page: 11
  ident: CR11
  article-title: Study of consanguinity in the Moroccan population. Impact on health profile
  publication-title: Antropo
  contributor:
    fullname: Chafik
– volume: 312
  start-page: 729
  issue: 7
  year: 2014
  end-page: 738
  ident: CR10
  article-title: Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States
  publication-title: JAMA
  doi: 10.1001/jama.2014.9132
  contributor:
    fullname: Currier
– volume: 31
  start-page: 778
  issue: 5
  year: 2011
  end-page: 783
  ident: CR16
  article-title: Severe combined immunodeficiency in Greek children over a 20-year period: rarity of γ c-chain deficiency (X-Linked) type
  publication-title: J Clin Immunol.
  doi: 10.1007/s10875-011-9564-0
  contributor:
    fullname: Villa
– volume: 64
  start-page: 543
  issue: 6
  year: 2012
  end-page: 554
  ident: CR21
  article-title: Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases
  publication-title: J Infect.
  doi: 10.1016/j.jinf.2012.03.012
  contributor:
    fullname: Rezaeib
– volume: 35
  start-page: 651
  year: 2015
  end-page: 660
  ident: CR8
  article-title: Primary immunodeficiency diseases in Saudi Arabia: a tertiary care hospital experience over a period of three years (2010–2013)
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-015-0197-6
  contributor:
    fullname: Al Gazlan
– volume: 123
  start-page: 564
  issue: 4
  year: 1993
  end-page: 572
  ident: CR13
  article-title: Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients
  publication-title: J Pediatr.
  doi: 10.1016/S0022-3476(05)80951-5
  contributor:
    fullname: Le Deist
– volume: 112
  start-page: 973
  issue: 5
  year: 2003
  end-page: 980
  ident: CR4
  article-title: Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2003.07.003
  contributor:
    fullname: Gelman
– volume: 35
  start-page: 517
  issue: 6
  year: 2015
  end-page: 518
  ident: CR12
  article-title: A-Project: a training program from ASID
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-015-0179-8
  contributor:
    fullname: Alao
– ident: CR20
– volume: 133
  start-page: 1134
  issue: 4
  year: 2014
  end-page: 1141
  ident: CR22
  article-title: BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies
  publication-title: J Allergy Clin Immunol.
  doi: 10.1016/j.jaci.2014.02.028
  contributor:
    fullname: Joshi
– volume: 9
  start-page: 782
  year: 2018
  ident: 960_CR9
  publication-title: Front immunol
  doi: 10.3389/fimmu.2018.00782
  contributor:
    fullname: H Almousa
– volume: 123
  start-page: 564
  issue: 4
  year: 1993
  ident: 960_CR13
  publication-title: J Pediatr.
  doi: 10.1016/S0022-3476(05)80951-5
  contributor:
    fullname: JL Stephan
– volume: 122
  start-page: 3749
  issue: 23
  year: 2013
  ident: 960_CR17
  publication-title: Blood
  doi: 10.1182/blood-2013-02-380105
  contributor:
    fullname: H Bobby Gaspar
– volume: 35
  start-page: 651
  year: 2015
  ident: 960_CR8
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-015-0197-6
  contributor:
    fullname: B Al-Saud
– volume: 33
  start-page: 1156
  issue: 7
  year: 2013
  ident: 960_CR23
  publication-title: J Clin Immunol.
  doi: 10.1007/s10875-013-9917-y
  contributor:
    fullname: CC Dvorak
– volume: 31
  start-page: 281
  issue: 2
  year: 2011
  ident: 960_CR15
  publication-title: J Clin Immunol.
  doi: 10.1007/s10875-010-9489-z
  contributor:
    fullname: PP Lee
– volume: 38
  start-page: 129
  issue: 1
  year: 2018
  ident: 960_CR5
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-017-0465-8
  contributor:
    fullname: AA Bousfiha
– volume: 157
  start-page: 3
  issue: suppl 1
  year: 2009
  ident: 960_CR7
  publication-title: Clin Exp Immunol.
  doi: 10.1111/j.1365-2249.2009.03954.x
  contributor:
    fullname: B Gathmann
– volume: 35
  start-page: 517
  issue: 6
  year: 2015
  ident: 960_CR12
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-015-0179-8
  contributor:
    fullname: NHH Erwa
– volume: 312
  start-page: 729
  issue: 7
  year: 2014
  ident: 960_CR10
  publication-title: JAMA
  doi: 10.1001/jama.2014.9132
  contributor:
    fullname: A Kwan
– volume: 27
  start-page: 299
  issue: 5
  year: 2017
  ident: 960_CR18
  publication-title: J Investig Allergol Clin Immunol.
  doi: 10.18176/jiaci.0147
  contributor:
    fullname: MR Fazlollahi
– volume: 10
  start-page: 23
  year: 2019
  ident: 960_CR2
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.00023
  contributor:
    fullname: J Aluri
– volume: 64
  start-page: 543
  issue: 6
  year: 2012
  ident: 960_CR21
  publication-title: J Infect.
  doi: 10.1016/j.jinf.2012.03.012
  contributor:
    fullname: S Norouzia
– ident: 960_CR20
  doi: 10.1016/j.jaip.2015.01.026
– volume: 40
  start-page: 66
  issue: 1
  year: 2020
  ident: 960_CR6
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-020-00758-x
  contributor:
    fullname: SG Tangye
– volume: 15
  start-page: 1
  year: 2007
  ident: 960_CR11
  publication-title: Antropo
  contributor:
    fullname: J Talbi
– volume: 31
  start-page: 778
  issue: 5
  year: 2011
  ident: 960_CR16
  publication-title: J Clin Immunol.
  doi: 10.1007/s10875-011-9564-0
  contributor:
    fullname: A Michos
– volume: 10
  start-page: 1908
  year: 2019
  ident: 960_CR19
  publication-title: Frontiers in Immunol.
  doi: 10.3389/fimmu.2019.01908
  contributor:
    fullname: E Cirillo
– volume: 124
  start-page: 1152
  issue: 6
  year: 2009
  ident: 960_CR3
  publication-title: J Allergy Clin Immunol.
  doi: 10.1016/j.jaci.2009.10.022
  contributor:
    fullname: LM Griffith
– volume: 112
  start-page: 973
  issue: 5
  year: 2003
  ident: 960_CR4
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2003.07.003
  contributor:
    fullname: WT Shearer
– volume: 133
  start-page: 1134
  issue: 4
  year: 2014
  ident: 960_CR22
  publication-title: J Allergy Clin Immunol.
  doi: 10.1016/j.jaci.2014.02.028
  contributor:
    fullname: BE Marciano
– volume: 1356
  start-page: 90
  year: 2015
  ident: 960_CR1
  publication-title: Ann N Y Acad Sci.
  doi: 10.1111/nyas.12849
  contributor:
    fullname: E Cirillo
– volume: 175
  start-page: 68
  issue: 1
  year: 2014
  ident: 960_CR14
  publication-title: Clin Exp Immunol
  doi: 10.1111/cei.12172
  contributor:
    fullname: JD Edgar
SSID ssj0003625
Score 2.3760588
Snippet Severe combined immunodeficiency (SCID) is a heterogeneous group of primary immunodeficiency diseases (PIDs) characterized by a lack of autologous T...
SourceID proquest
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 631
SubjectTerms Alleles
Autografts
Biomarkers
Biomedical and Life Sciences
Biomedicine
Candidiasis
Children
Chronic infection
Consanguinity
Cross-Sectional Studies
Diagnosis
Diagnosis, Differential
Diarrhea
Disease Management
Disease Susceptibility
Epidemiology
Genetic Predisposition to Disease
Genotype
Genotype & phenotype
Hematopoietic stem cells
Humans
Immunology
Infectious Diseases
Inheritance Patterns
Internal Medicine
Lymphocytes T
Lymphopenia
Medical Microbiology
Morocco - epidemiology
Original Article
Patients
Phenotype
Phenotypes
Primary immunodeficiencies
Public Health Surveillance
Recurrent infection
Respiratory tract diseases
Severe combined immunodeficiency
Severe Combined Immunodeficiency - diagnosis
Severe Combined Immunodeficiency - epidemiology
Severe Combined Immunodeficiency - etiology
Stem cell transplantation
SummonAdditionalLinks – databaseName: Public Health Database
  dbid: 8C1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEA66gngR364vInjTYNO0aeNFZHVZhRVBBW8ljwYRaVd3F_fo3_Dv-UucdFOLiNJjShtmMjPfTOaB0IHhsZtKGJBEiohEOjZEpNoQG1KrQxXopBrn07_mvfvo6iF-8AG3oU-rrHVipahNqV2M_BjcBNCjPOXsdPBC3NQod7vqR2jMojkKds45X2mnSfEA5VylMIYJBaGOQl8040vnAKkT5zxVKJ5MfhqmX2jz101pZYC6S2jRI0d8NmX1MprJixU03_d346voybf4fMayMPjS1X3Uig07oDcGxxqXFguO-yWYLaAp7vhSbuzCsfi2c3mObx7zonSB2RN891bi89wl0A8_3z9w0xV5Dd13L-46PeInKRDNknhEZKyMBfHlNqWaCimZMkzFOhSx0SKSUkkbGxpK5vqZcUqZCqwEqCdFIqmybB21irLINxFOIsWNTiMrhYh0IkHec3gCTa2hgWFtdFiTMRtMG2ZkTWtkR_QMiJ5VRM8mbbRTUzrzwjPMGla30f73Mhx7d5chi7wcu3cSwGaci7CNNqYc-v4dA8sMQBdWjmqWNR__ey9b_-9lGy2ELp-lytrZQa3R6zjfBUAyUnvVqfsCvyXbgQ
  priority: 102
  providerName: ProQuest
Title Clinical and Immunological Features of 96 Moroccan Children with SCID Phenotype: Two Decades’ Experience
URI https://link.springer.com/article/10.1007/s10875-020-00960-x
https://www.ncbi.nlm.nih.gov/pubmed/33411152
https://www.proquest.com/docview/2494716863
https://search.proquest.com/docview/2476126692
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fb9MwED9BJyFexn9WNiYj8QaeYie2Y95K17GBOk3QSuUp8p9YaEMJYq1APPE19vX4JJzTpAUVHqZIiRRHTuKz73723e8M8NxLEXclTKgyOqOZE57q3HkaOAuO28SpZjuf8ak8nmZvZ2K25nE3we6dR7JR1H9w3RBa0zjbaWA3ReC4FYmnogdbgzcf341WChh1chO5yBXDsZzxlivz71r-tkcbIHPDQdrYnaM7MOnYO8twk4uDxdweuB-byRyv80t3YbvFoWSw7Dj34EZZ3Ydb49bT_gDO24Shn4mpPDmJLJJOTZIIGxc4TSd1IFqScY1GECVEhi0xnMTFXfJheHJIzj6VVR2XeV-RybeaHJYxHP_y188rss6x_BCmR6PJ8Ji2-zJQlyoxp0ZYH1AZyJAzx7QxqfWpFY5r4Z3OjLEmCM-4SWN2NMlYapNgEDgarQyzIX0Evaquyh0gKrPSuzwLRuvMKYPao8QjcSx4lvi0Dy866RRfluk3inWi5dh8BTZf0TRf8b0Pe50Ai3YoXhY4v0QDLHOJlT1bFeMgip4RU5X1Ij6jEOlJqXkfHi8Fv3pdinYeYTOWvOykuK78_9_y5HqP78JtHqNlmpigPejNvy7Kpwh35nYfbqqZwnM-ZPttV8fr69Hp2Xu8O-WD3yYh-Zw
link.rule.ids 315,783,787,12070,12237,21402,27938,27939,31733,31734,33280,33281,33758,33759,41095,41537,42164,42606,43324,43593,43819,52125,52248,74081,74350,74638
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_BkGAvaHyuMMBIvIFFHCd2zcuEOqYW1gmJTupb5I9YCKFk0FbskX9j_97-Eu5SpxWaQHl0lFh3vrvfne8D4FVQJU0lzLi2puCFLwM3Qx94zEX0ucu87sb5TE_V-Kz4OC_nKeC2SGmVvU7sFHVoPcXI36KbgHpUDZU8PP_BaWoU3a6mERo34Rb14aLe-Xq-cbhIOXcpjLkWKNRFnopmUukcInVOzlOH4vnF34bpGtq8dlPaGaDjPbibkCN7v2b1PbhRN_fh9jTdjT-Ab6nF53dmm8AmVPfRKzZGQG-FjjVrIzOKTVs0W0hTNkql3IzCsezLaHLEPn-tm5YCs-_Y7FfLjmpKoF9c_b5k267ID-Hs-MNsNOZpkgL3UpdLbksXIoqvikPhhbFWuiBd6XNTBm8Ka52NZRC5ldTPTAkhXRYtQj1rtBUuykew07RNvQ9MF04FPyyiNabw2qK81_hkXsQgsiAH8LonY3W-bphRbVsjE9ErJHrVEb26GMBBT-kqCc-i2rJ6AC83y3js6S7DNnW7onc0YjOlTD6Ax2sObX4n0TIj0MWVNz3Lth__916e_H8vL-DOeDY9qU4mp5-ewm5OuS1dBs8B7Cx_rupnCE6W7nl3Av8AcVfeoA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFD6CTpp4QeO6wgAj8QbW4tixa14QtKtWoFUFm7S3yJdYCKFk0Fbb4_7G_h6_hOPUaYUmUB4dJda5fva5AbzysohTCTOqjBZUuMJTPXCehpwFl9vMqXacz3Qmj0_Fx7PiLOU_LVJaZWcTW0PtGxfvyA_xmIB2VA4kPwwpLWI-Gr87_0njBKkYaU3jNG7DjhIoVT3Y-XA0m3_Z2GU01W1CY64YqrjIUwlNKqRD3E7jUarF9PTybzd1A3veiJu27mi8B3cTjiTv14y_B7eq-j7sTlOk_AF8Tw0_fxBTezKJVSCdmSMR9q3wmE2aQLQk0wadGFKYDFNhN4mXs-TrcDIi829V3cRr2rfk5KIhoyqm0y9-X12TbY_kh3A6PjoZHtM0V4E6roolNYX1AZVZhgFzTBvDree2cLkuvNPCGGtC4VlueOxuJhnjNgsGgZ_RyjAb-CPo1U1d7QNRwkrvBiIYrYVTBrW_widzLHiWed6H1x0Zy_N1-4xy2yg5Er1Eopct0cvLPhx0lC6TKi3KLeP78HKzjEoQIxumrppVfEchUpNS5314vObQ5ncc_TTCXlx507Fs-_F_7-XJ__fyAnZR_MrPk9mnp3Anj4kubTrPAfSWv1bVM0QqS_s8ieAf66_kQw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+and+Immunological+Features+of+96+Moroccan+Children+with+SCID+Phenotype%3A+Two+Decades%E2%80%99+Experience&rft.jtitle=Journal+of+clinical+immunology&rft.au=Benhsaien%2C+Ibtihal&rft.au=Ailal%2C+Fatima&rft.au=El+Bakkouri%2C+Jalila&rft.au=Jeddane%2C+Le%C3%AFla&rft.date=2021-04-01&rft.pub=Springer+US&rft.issn=0271-9142&rft.eissn=1573-2592&rft.volume=41&rft.issue=3&rft.spage=631&rft.epage=638&rft_id=info:doi/10.1007%2Fs10875-020-00960-x&rft.externalDocID=10_1007_s10875_020_00960_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0271-9142&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0271-9142&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0271-9142&client=summon